These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9772705)

  • 21. Pharmacokinetics of acyclovir in rabbit skin after i.v.-bolus, ointment, and iontophoretic administrations.
    Stagni G; Ali ME; Weng D
    Int J Pharm; 2004 Apr; 274(1-2):201-11. PubMed ID: 15072796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tc-NGA imaging in liver transplantation: preclinical studies.
    Woodle ES; Vera DR; Stadalnik RC; Ward RE
    Surgery; 1987 Jul; 102(1):55-62. PubMed ID: 3296267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo ocular pharmacokinetics of acyclovir dipeptide ester prodrugs by microdialysis in rabbits.
    Anand BS; Katragadda S; Gunda S; Mitra AK
    Mol Pharm; 2006; 3(4):431-40. PubMed ID: 16889437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study on liver targeted valaciclovir polybutylcyanoacrylate nanoparticles].
    Zhang Z; He Q
    Yao Xue Xue Bao; 1998 Sep; 33(9):702-6. PubMed ID: 12016876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic penetration of ethosomes and lipophilic prodrug on the transdermal delivery of acyclovir.
    Zhou Y; Wei YH; Zhang GQ; Wu XA
    Arch Pharm Res; 2010 Apr; 33(4):567-74. PubMed ID: 20422366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-assembled drug delivery systems. 1. Properties and in vitro/in vivo behavior of acyclovir self-assembled nanoparticles (SAN).
    Jin Y; Tong L; Ai P; Li M; Hou X
    Int J Pharm; 2006 Feb; 309(1-2):199-207. PubMed ID: 16377106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver targeting and anti-HBV activity of reconstituted HDL-acyclovir palmitate complex.
    Feng M; Cai Q; Huang H; Zhou P
    Eur J Pharm Biopharm; 2008 Mar; 68(3):688-93. PubMed ID: 17890068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of in vivo receptor measurements via in vitro radioassay: technetium-99m-galactosyl-neoglycoalbumin as prototype model.
    Kudo M; Vera DR; Trudeau WL; Stadalnik RC
    J Nucl Med; 1991 Jun; 32(6):1177-82. PubMed ID: 2045931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous infusion of cereport increases uptake and efficacy of acyclovir in herpes simplex virus-infected rat brains.
    Bidanset DJ; Placidi L; Rybak R; Palmer J; Sommadossi JP; Kern ER
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2316-23. PubMed ID: 11451691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacokinetic studies on 99mTc-NGA in human].
    Guan C; Chen Q; Tan T
    Hua Xi Yi Ke Da Xue Xue Bao; 1993 Sep; 24(3):268-70. PubMed ID: 8288194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of chitosan, benzalkonium chloride and ethylenediaminetetraacetic acid on permeation of acyclovir across isolated rabbit cornea.
    Majumdar S; Hippalgaonkar K; Repka MA
    Int J Pharm; 2008 Feb; 348(1-2):175-8. PubMed ID: 17897799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of the treatment protocol upon the in vivo efficacy of cidofovir (HPMPC) and of acyclovir (ACV) formulations in topical treatment of cutaneous HSV-1 infection in hairless mice.
    Afouna MI; Mehta SC; Ghanem AH; Higuchi WI; Kern ER; DeClercq E; El-Shattawy HH
    J Pharm Sci; 1999 May; 88(5):530-4. PubMed ID: 10229644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of valacyclovir in the adult horse.
    Maxwell LK; Bentz BG; Bourne DW; Erkert RS
    J Vet Pharmacol Ther; 2008 Aug; 31(4):312-20. PubMed ID: 18638291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amino acid prodrugs of acyclovir as possible antiviral agents against ocular HSV-1 infections: interactions with the neutral and cationic amino acid transporter on the corneal epithelium.
    Anand BS; Katragadda S; Nashed YE; Mitra AK
    Curr Eye Res; 2004; 29(2-3):153-66. PubMed ID: 15512962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Technetium-99m galactosyl-neoglycoalbumin: preparation and preclinical studies.
    Vera DR; Stadalnik RC; Krohn KA
    J Nucl Med; 1985 Oct; 26(10):1157-67. PubMed ID: 4045560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The preparation of 99mTc-NGA instant lyophilized kit for hepatic imaging].
    Guan C; Chen Q; Tan T
    Hua Xi Yi Ke Da Xue Xue Bao; 1993 Dec; 24(4):429-32. PubMed ID: 8150449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of human hepatic binding protein (HBP) via 99mTc-galactosyl-neoglycoalbumin (NGA) liver scintigraphy.
    Virgolini I; Müller C; Angelberger P; Höbart J; Bergmann H; Sinzinger H
    Wien Klin Wochenschr; 1991; 103(15):458-61. PubMed ID: 1926872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on acyclovir-dextran conjugate: synthesis and pharmacokinetics.
    Tu J; Zhong S; Li P
    Drug Dev Ind Pharm; 2004; 30(9):959-65. PubMed ID: 15554220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel radioiodination reagent for protein radiopharmaceuticals with L-lysine as a plasma-stable metabolizable linkage to liberate m-iodohippuric acid after lysosomal proteolysis.
    Wakisaka K; Arano Y; Uezono T; Akizawa H; Ono M; Kawai K; Ohomomo Y; Nakayama M; Saji H
    J Med Chem; 1997 Aug; 40(16):2643-52. PubMed ID: 9258371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovir.
    Masuda T; Yoshihashi Y; Yonemochi E; Fujii K; Uekusa H; Terada K
    Int J Pharm; 2012 Jan; 422(1-2):160-9. PubMed ID: 22079714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.